WEDNESDAY, Dec. 28, 2022 (HealthDay News) — A new study is adding to evidence that people with multiple sclerosis can benefit from a type of stem cell transplant — including some patients who are in a more advanced phase of the disease. The research is the latest look at aContinue Reading
FRIDAY, Dec. 16, 2022 (HealthDay News) — Extreme fatigue often tops the list of the most distressing symptoms for millions of people who live with multiple sclerosis (MS). And now, a new study suggests that light therapy may help these folks get their lives back. MS is an autoimmune diseaseContinue Reading
WEDNESDAY, Nov. 2, 2022 (HealthDay News) — Obesity is never healthy, and that may be especially true for people who also develop multiple sclerosis. Obese people with MS are likely to see the disability linked to the disease rapidly worsen, said German researchers who followed more than 1,000 patients inContinue Reading
TUESDAY, Oct. 18, 2022 (HealthDay News) — Actress Selma Blair made one last waltz through the “Dancing with the Stars” ballroom on Monday night. The actress, who has multiple sclerosis, announced during the show that it would be her last turn on the dance floor because of the impact onContinue Reading
MONDAY, Sept. 26, 2022 (HealthDay News) — Scientists have been looking to the microbiome, and its numerous gut bacteria, as an area of research with plenty of potential for finding connections to various diseases. Now, scientists have found evidence of significant differences between the gut bacteria of individuals who haveContinue Reading
WEDNESDAY, Aug. 31, 2022 (HealthDay News) — Research has linked heart disease to specific autoimmune diseases such as rheumatoid arthritis and lupus. Now, a huge study shows that autoimmune diseases as a group increase your chances of developing heart ills. Autoimmune diseases such as psoriasis, multiple sclerosis, lupus erythematosus andContinue Reading
THURSDAY, Aug. 25, 2022 (HealthDay News) — An experimental antibody therapy for multiple sclerosis can cut symptom flare-ups by half, versus a standard treatment, a new clinical trial has found. The drug, called ublituximab, beat a standard oral medication for MS in reducing patients’ relapses — periods of new orContinue Reading
THURSDAY, Aug. 25, 2022 (HealthDay News) — Vitamin D exposure, or lack of it, has long been thought to influence the risk of developing multiple sclerosis (MS) because the disease is diagnosed more often in people in northern countries. However, new research suggests there might be an additional reason whyContinue Reading
THURSDAY, Aug. 11, 2022 (HealthDay News) — For people with multiple sclerosis, certain factors early in their disease may determine their quality of life in the years to come, a new study suggests. In medicine, there are ways to objectively measure a disease’s course, such as whether a medication isContinue Reading
THURSDAY, July 14, 2022 (HealthDay News) — A drug used “off-label” for multiple sclerosis (MS) is more effective than a standard medication at preventing symptom flare-ups, a new clinical trial has found. The drug, called rituximab, is approved in the United States for treating certain cancers and autoimmune diseases. ItContinue Reading
THURSDAY, May 5, 2022 (HealthDay News) — Two experimental vaccines show promise in protecting against infection with the “mono” virus, which also causes cancer and has been implicated as a potential trigger of multiple sclerosis, a new paper reports. Tested only in animals so far, the vaccines block two pathwaysContinue Reading
TUESDAY, May 3, 2022 (HealthDay News) — Black Americans are as likely to get multiple sclerosis (MS) as their white counterparts, but rates are much lower among Hispanic and Asian Americans, new research shows. The findings refute the long-held belief that MS is rare in Black people, according to theContinue Reading
THURSDAY, April 14, 2022 (HealthDay News) — In 2019 alone, multiple sclerosis (MS) cost Americans an estimated $85.4 billion, a new study finds. That amount included over $63 billion in direct medical costs and $22 billion in indirect non-medical costs. “The findings of this study help underscore the burden ofContinue Reading
THURSDAY, March 3, 2022 (HealthDay News) — Telemedicine was widely used by Americans with multiple sclerosis (MS) during the pandemic, and many were happy with the results, a new study finds. “The findings suggest that telehealth services were well liked during the pandemic. Because many individuals with MS have physicalContinue Reading